All In Biotech

Free tool

FAERS Monitor: Rifadin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050627 or its brand name (Rifadin, Rifampin). Reports on generic versions are filed under their own applications.

Reports

10,069

Serious

9,802

97% of reports

Hospitalization

4,801

Death reported

1,594

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction1,008
  • pyrexia919
  • drug reaction with eosinophilia and systemic symptoms558
  • drug ineffective518
  • vomiting452
  • drug-induced liver injury442
  • nausea394
  • acute kidney injury362
  • jaundice360
  • condition aggravated347
  • thrombocytopenia310
  • rash302
  • paradoxical drug reaction295
  • eosinophilia287
  • drug resistance268

Reports by year received

View as table
YearReports
2004214
2005242
2006308
2007255
2008316
2009337
2010337
2011331
2012516
2013558
2014555
2015676
2016721
2017917
20181,082
20191,023
2020929
2021610
202233
202334
202423
202528
202620

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,090 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
paradoxical drug reactionSignal295182.0161.848,685
drug reaction with eosinophilia and systemic symptomsSignal55846.342.724,170
eosinophiliaSignal28734.831.09,233
drug-induced liver injurySignal44229.827.212,133
jaundiceSignal36028.325.69,346
drug resistanceSignal26822.019.55,305
drug interactionSignal1,00813.412.611,519
thrombocytopeniaSignal3105.85.21,231
pyrexiaSignal9195.65.23,481
acute kidney injurySignal3625.04.51,143
condition aggravatedSignal3472.42.2282
vomitingSignal4522.01.8233
rash3021.41.342
nausea3941.00.91
drug ineffective5180.80.821

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.